Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Immune Paralysis in Septic Shock (RODIS)
NCT03989609Phase 2Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jun 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in septic shock, sponsored by Kasr Al Ainy Hospital. Started Jun 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03989609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03989609.